chartexchange

Pelthos and Castle Creek plan merger to target skin diseases

Pharmaceutical Technology | Nov 2, 2026 4:55 AM EST

Pelthos Therapeutics has agreed to merge with Castle Creek Biosciences to form a new biotechnology company that will focus on serious diseases affecting the skin.

Read original article